Roche announces FDA approval of Xofluza (baloxavir marboxil) for influenza

Roche today announced that the US Food and Drug Administration (FDA) has approved Xofluza ™ (baloxavir marboxil) for the treatment of acute, uncomplicated influenza, or flu, in people 12 years of age and older.
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news